• 제목/요약/키워드: Breast Cancer Screening

검색결과 397건 처리시간 0.026초

유방촬영 시 몬테칼로 전사모사를 이용한 유방 성형 환자의 장기선량 평가 (Assessment of Organ Dose in Mammoplasty Patient by Monte Carlo Simulation during Mammography)

  • 김지수;조용인;김정훈
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제43권5호
    • /
    • pp.337-341
    • /
    • 2020
  • Although the screening with a mammography has been shown to be economical, simple and effective in detecting breast cancer, it is accompanied by the risk from radiation. Therefore, this study analyzed the glandular dose and organ dose according to the target-filter combination and the presence and absence of implants using Monte Carlo simulation. The results indicate that at a tube voltage of 30 kV and a tube current of 50 mAs, the dose increased in the order of Mo/Mo. Mo/Rh, Rh/Rh and W/Rh in proportion to the atomic number of the target-filter. In addition, in phantom without implant a reduction in dose was seen when compared to the phantom with implant. The organ dose was highest in the lens except for the breast on the examination side regardless of the presence or absence of the implant. These results may contribute to use basic data for the diagnostic reference level of breast plastic surgery patients.

유방촬영술 유도하 중재 시술 (Mammography-Guided Interventional Procedure)

  • 최우정;김학희
    • 대한영상의학회지
    • /
    • 제84권2호
    • /
    • pp.320-331
    • /
    • 2023
  • 유방촬영술을 이용한 유방암 검진은 표준 영상 방법이다. 초음파에서 보이지 않고 유방촬영술이나 디지털 유방 토모신테시스에서만 보이는 의심스러운 석회화, 구조 왜곡의 조직학적 진단을 위해 입체정위생검과 유방촬영술 유도하 수술 전 위치결정술을 시행한다. 본 종설에서는 입체정위생검의 적응증 및 비적응증, 방법, 입체정위생검 후 클립 삽입과 디지털 유방 토모신테시스 유도하 입체정위생검에 대해 알아보고자 한다. 또한, 유방촬영술 유도하 수술 전 위치결정술을 침위치결정술과 비침위치결정술로 나누어 소개하고자 한다.

Molecular Profiling of Breast Carcinoma in Almadinah, KSA: Immunophenotyping and Clinicopathological Correlation

  • Elkablawy, Mohamed A;Albasry, Abdelkader M;Hussainy, Akbar S;Nouh, Magdy M;Alhujaily, Ahmed
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권17호
    • /
    • pp.7819-7824
    • /
    • 2015
  • Purpose: To subtype breast cancer (BC) in Saudi women according to the recent molecular classification and to correlate these subtypes with available clinicopathological parameters. Materials and Methods: Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (Her2/neu) immunostaining was semi-quantitatively assessed to define molecular subtypes of luminal A and B, HER-2 and triple negative (basal-like) in BC paraffin embedded sections from 115 Saudi female patients diagnosed between 2005 to 2015 at the Department of Pathology, King Fahd Hospital, Almadinah, Saudi Arabia. Results: The most common subtypes were luminal A (47%), followed by luminal B (27.8%) and basal like subtypes (18.3%), whereas HER-2 was the least common subtype (6.9%). Luminal A was predominantly found in the old age group, with low tumor grade (p<0.001) and small tumor size, whereas HER-2 and basal-like subtypes were significantly associated with young age, high tumor grade, lymph node metastasis and lymphovascular invasion (p<0.03, 0.004, 0.05 and 0.04 respectively). All subtypes showed advanced clinical stage at the time of presentation. Conclusions: Molecular subtypes of Saudi BC patients in Almadinah region are consistent with most of the worldwide subtyping. The biological behaviour of each molecular subtype could be expected based on its characteristic clinicopathological features. Along with other prognostic indicators, molecular subtyping would be helpful in predicting prognosis and management of our BC patients. We recommend screening and early diagnosis of BC in our population.

Clinical Features of Lung Cancer in Japanese Patients Aged Under 50

  • Igata, Fumiyasu;Uchino, Junji;Fujita, Masaki;Iwasaki, Akinori;Watanabe, Kentaro
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권7호
    • /
    • pp.3377-3380
    • /
    • 2016
  • The proportion of lung cancer patients under 50 years old is small at approximately 5-10%, but as with patients older than 50, the number is on the rise. Although lung cancer treatment strategies have undergone extensive transformation in recent years based on the presence or absence of oncogenic driver mutations, there are few reports regarding these mutations in the young or the relationship between clinical setting and prognosis. Therefore, we conducted a study of clinical features in 36 patients under the age of 50 who were diagnosed with primary lung cancer from October 2008 to November 2015. The 22 patients in stages I through III A underwent operations, and all 17 whose lung cancer were detected through screening were candidates for surgery. Gene analysis was conducted for 26 (72.2%); 10 (38.5%) were positive for EGFR gene mutations, and ALK gene translocation was present in 4 (15.4%). In stage IV patients, the median progression free survival (PFS) in the ALK translocation positive and negative patients was 518 days and 130 days, respectively, and the median overall survival (OS) was not reached and 280 days, respectively. A trend toward extended PFS (p=0.203) and OS (p=0.056) was observed in patients positive for ALK translocation. We must strive for early detection by increasing screening rates and evaluate oncogenic driver mutations important for prognosis of lung cancer in the young.

Quantification of Her-2/Neu Gene in Breast Cancer Patients using Real Time-Polymerase Chain Reaction (Q-PCR) and Correlation with Immunohistochemistry Findings

  • Abdul Murad, Nor Azian;Razak, Zuraini Abdul;Hussain, Rosniza Muhammmad;Syed Hussain, Sharifah Noor Akmal;Ching Huat, Clarence Ko;Siti Aishah, Che Md. Ali;Abdullah, Norlia;Muhammad, Rohaizak;Ibrahim, Naqiyah;Jamal, Rahman
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권3호
    • /
    • pp.1655-1659
    • /
    • 2013
  • Background: HER-2/neu is a proto-oncogene that encodes a transmembrane tyrosine kinase growth factor which is crucial for stimulating growth and cellular motility. Overexpression of HER-2/neu is observed in 10-35% of human breast cancers and is associated with pathogenesis, prognosis as well as response to therapy. Given the imperative role of HER-2/neu overexpression in breast cancer, it is important to determine the magnitude of amplification which may facilitate a better prognosis as well as personalized therapy in affected patients. In this study, we determined HER-2/neu protein expression by immunohistochemistry (IHC) concurrently with HER-2/neu DNA amplification by quantitative real time-polymerase chain reaction (Q-PCR). Materials and Methods: A total of 53 paired tissue samples from breast cancer patients were frozen-sectioned to characterize the tumour and normal tissues. Only tissues with 80% tumour cells were used in this study. For confirmation, Q-PCR was used to determine the HER-2/neu DNA amplification. Results: We found 20/53 (37.7%) of the tumour tissues to be positive for HER-2/neu protein overexpression using IHC. Out of these twenty, only 9/53 (17%) cases were in agreement with the Q-PCR results. The concordance rate between IHC and Q-PCR was 79.3%. Approximately 20.7% of positive IHC cases showed no HER-2/neu gene amplification using Q-PCR. Conclusion: In conclusion, IHC can be used as an initial screening method for detection of the HER-2/neu protein overexpression. Techniques such as Q-PCR should be employed to verify the IHC results for uncertain cases as well as determination of HER-2/neu gene amplification.

Stereotactic Vacuum-Assisted Core Biopsy Results for Non-Palpable Breast Lesions

  • Agacayak, Filiz;Ozturk, Alper;Bozdogan, Atilla;Selamoglu, Derya;Alco, Gul;Ordu, Cetin;Pilanci, Kezban Nur;Killi, Refik;Ozmen, Vahit
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권13호
    • /
    • pp.5171-5174
    • /
    • 2014
  • Background: The increase in breast cancer awareness and widespread use of mammographic screening has led to an increased detection of (non-palpable) breast cancers that cannot be discovered through physical examination. One of the methods used in the diagnosis of these cancers is vacuum-assisted core biopsy, which prevents a considerable number of patients from undergoing surgical procedures. The aim of this study was to present the results of stereotactic vacuum-assisted core biopsy for suspicious breast lesions. Materials and Methods: Files were retrospectively scanned and data on demographic, radiological and pathological findings were recorded for patients who underwent stereotactic vacuum-assisted core biopsy due to suspicious mammographic findings at the Interventional Radiology Centre of the Florence Nightingale Hospital between January 2010, and April 2013. Statistical analysis was carried out using Pearson's Chi-square, continuity correction, and Fisher's exact tests. Results: The mean age of the patients was 47 years (range: 36-70). Biopsies were performed due to BIRADS 3 lesions in 8 patients, BIRADS 4 lesions in 77 patients, and BIRADS 5 lesions in 3 patients. Mammography elucidated clusters of microcalcifications in 73 patients (83%) and focal lesions (asymmetrical density, distortion) in 15 patients (17%). In terms of complications, 1 patient had a hematoma, and 2 patients had ecchymoses (3/88; 3.3%). The histopathologic results revealed benign lesions in 63 patients (71.6%) and malignant lesions in 25 patients (28.4%). The mean duration of the procedure was 37 minutes (range: 18-55). Although all of the BIRADS 3 lesions were benign, 22 (28.6%) of the BIRADS 4 lesions and all of the BIRADS 5 lesions were malignant. Among the malignant cases, 80% were in situ, and 20% were invasive carcinomas. These patients underwent surgery. Conclusions: In cases where non-palpable breast lesions are considered to be suspicious in mammography scans, the vacuum-assisted core biopsy method provides an accurate histopathologic diagnosis thus preventing a significant number of patients undergoing unnecessary surgical procedures.

피셔 분별 사전학습을 이용해 개선된 Sparse 표현 기반 악성 종괴 검출 (Improvement of Sparse Representation based Classifier using Fisher Discrimination Dictionary Learning for Malignant Mass Detection)

  • 김성태;이승현;민현석;노용만
    • 한국멀티미디어학회논문지
    • /
    • 제16권5호
    • /
    • pp.558-565
    • /
    • 2013
  • X-ray를 이용한 여성의 유방암 검사인 유방조영술은 유방암의 초기 단계에서의 진단을 위한 효과적인 방법이다. 컴퓨터 지원 검출(CAD) 시스템은 유방조영술을 통한 진단 시 의사가 놓치기 쉬운 유방암의 징후인 종괴의 검출을 도와 유방암 진단율을 높이는 수단이다. 종괴는 다양한 모양을 지니며 경계가 뚜렷하지 않기 때문에 검출이 어렵고 결과적으로 비-종괴 영역을 포함한 많은 수의 종괴 후보영역이 CAD 시스템에서 검출된다. 따라서 CAD 시스템 설계 시 검출된 많은 수의 종괴 후보영역으로부터 실제 악성 종괴 영역을 분류할 수 있도록 우수한 성능의 분류기가 요구된다. 본 논문에서는 피셔 분별 사전학습을 통해 개선된 Sparse 표현(SR) 기반 분류방법을 제안한다. 개선된 SR 기반 분류기가 기존의 CAD 시스템에서 주로 사용되어온 Support Vector Machine (SVM) 분류기 보다 우수함을 비교실험을 통해 확인했다.

An Optimized Deep Learning Techniques for Analyzing Mammograms

  • Satish Babu Bandaru;Natarajasivan. D;Rama Mohan Babu. G
    • International Journal of Computer Science & Network Security
    • /
    • 제23권7호
    • /
    • pp.39-48
    • /
    • 2023
  • Breast cancer screening makes extensive utilization of mammography. Even so, there has been a lot of debate with regards to this application's starting age as well as screening interval. The deep learning technique of transfer learning is employed for transferring the knowledge learnt from the source tasks to the target tasks. For the resolution of real-world problems, deep neural networks have demonstrated superior performance in comparison with the standard machine learning algorithms. The architecture of the deep neural networks has to be defined by taking into account the problem domain knowledge. Normally, this technique will consume a lot of time as well as computational resources. This work evaluated the efficacy of the deep learning neural network like Visual Geometry Group Network (VGG Net) Residual Network (Res Net), as well as inception network for classifying the mammograms. This work proposed optimization of ResNet with Teaching Learning Based Optimization (TLBO) algorithm's in order to predict breast cancers by means of mammogram images. The proposed TLBO-ResNet, an optimized ResNet with faster convergence ability when compared with other evolutionary methods for mammogram classification.